ELEVATED BLOOD PRESSURE IS ASSOCIATED WITH AN INCREASED risk of
cardiovascular illness and death. Efforts to reduce that risk have led to recommendations for …

Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …

Background Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin
receptor blockers (ARBs) are widely prescribed for primary hypertension (systolic blood …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

Approximately 50 million Americans have hypertension. 8 As the population of the United
States increases in age, the burden of uncontrolled hypertension will continue to contribute …

Background: Hypertension is an important healthcare challenge, yet despite initiatives to
improve detection and advances in therapy, the majority of patients do not achieve …

Therapeutic goals for the treatment of hypertension and the ability of various angiotensin-
converting-enzyme (ACE) inhibitors to meet these goals are presented. The 1997 Sixth …

Abundant evidence has accumulated showing that angiotensin converting enzyme (ACE)
inhibitors reduce long-term cardiovascular morbidity and mortality rates in patients with heart …

Abstract Purpose of Review Angiotensin-converting enzyme inhibitors and angiotensin
receptor blockers are commonly used anti-hypertensive medications in a number of clinical …

The past decade has seen a shift in the strategy for hypertension treatment from stepped
therapy—a highly structured monolithic series of steps—to recommendations for a more …